New York-based Jones just raised $10 million to expand its nicotine lozenge company in the stodgy, $3 billion smoking cessation market.

Nicotine pouches haven’t been approved for use as NRT – so why are they becoming a popular alternative to smoking and vaping? Pouches are heavily marketed on social media and, unlike NRTs ...

A bill to tax vape products up to 10% – more than tobacco – and ban products not in the FDA approval process will likely see final votes next week.